3 Reasons HIMS Has Explosive Upside Potential
Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining …
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| المطلع | المنصب | التاريخ | النوع | القيمة |
|---|---|---|---|---|
| Pendarvis Christiane | Former Director | Jul 22 '26 | Proposed Sale | 113278,0 |
| Okupe Oluyemi | Chief Financial … | Jul 17 '26 | Option Exercise | 35887,0 |
| Okupe Oluyemi | Chief Financial … | Jul 17 '26 | Sale | 229168,0 |
| Okupe Oluyemi | Chief Financial … | Jul 06 '26 | Option Exercise | 35887,0 |
| Okupe Oluyemi | Chief Financial … | Jul 06 '26 | Sale | 261351,0 |
| Oluyemi Okupe | Officer | Jul 06 '26 | Proposed Sale | 1096799,0 |
| Carroll Patrick Harrison | Chief Medical … | Jun 18 '26 | Sale | 830410,0 |
| Okupe Oluyemi | Chief Financial … | Jun 22 '26 | Option Exercise | 31944,0 |
| Okupe Oluyemi | Chief Financial … | Jun 22 '26 | Sale | 619217,0 |
| Carroll Patrick Harrison | Officer | Jun 18 '26 | Proposed Sale | 830410,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر HIMS والمشاعر والاتجاه
Hims & Hers Health trades at $33.39 per share and has stayed right on track with the overall market, gaining …
Tuesday's catalysts include flash PMIs, Richmond Fed data, ADP weekly employment, Treasury bill and 2-year note auctions, and May money …
STORY: U.S. stocks ended mostly lower on Tuesday, but the Dow posted a modest gain, while the S&P 500 edged …
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on …
Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates amid increasing competition in …
The pace of first quarter earnings reports eases this week as economic data takes center stage, but investors will still …
تحليل متعدد المزودين بالذكاء الاصطناعي